Search Results

Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D

Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization

Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic

., D. Goswami, Y. Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013.

Wootten, D., et al., The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased

G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation Chiara D

Scribble scrambles parathyroid hormone receptor interactions to regulate phosphate and vitamin D homeostasis

First Protein Structures in PDB, Advances Lupus Therapy Research Structure Therapeutics Receives R&D

from September 30th to October 6th, 2024 Industry News Nxera Pharma appoints experienced commercial R&D

Wang, D., The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity

This Week’s Highlights: G protein-coupled receptor (GPCR) pharmacogenomics Miles D Thompson , David

Statins inhibit protein kinase D (PKD) activation in intestinal cells and prevent PKD1-induced growth

Araç, D., et al., A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis

CRS2), which will trigger conformational changes that ultimately lead to receptor activation (Scholten D

of functional redundancy, as depleting one isoform results leads to relatively mild effects (Conner, D.

Tilley, D. G. D. Regulation of nuclear factor κB activation by G-protein-coupled receptors.

to E2837.39 by A4 of CCL3; c) Route 3 - characterized by steric effects between TM2 and Y3 of CCL5; d)